deltatrials
Completed EARLY_PHASE1 INTERVENTIONAL 1-arm NCT03248947

Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder: CTN 0075 (Pharm-OUD-Care)

Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder: Clinical Trials Network 0075

Sponsor: Duke University

Conditions Opioid Use Disorder
Interventions Pharmacist-administered buprenorphine/naloxone maintenance care buprenorphine/naloxone
Updated 14 times since 2017 Last updated: Jul 26, 2021 Started: Mar 28, 2018 Primary completion: Jun 27, 2019 Completion: Jun 27, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A EARLY_PHASE1 clinical study on Opioid Use Disorder, this trial is completed. The trial is conducted by Duke University and has accumulated 14 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Sep 2017 – ~Mar 2018 · 6 months · monthly snapshot~Mar 2018 – ~May 2018 · 2 months · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Apr 2019 · 10 months · monthly snapshot~Apr 2019 – ~Jun 2019 · 2 months · monthly snapshot~Jun 2019 – ~Aug 2019 · 2 months · monthly snapshot~Aug 2019 – ~Sep 2020 · 13 months · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Dec 2022 · 15 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed EARLY_PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed EARLY_PHASE1

  3. Jan 2023 — Jul 2024 [monthly]

    Completed EARLY_PHASE1

  4. Dec 2022 — Jan 2023 [monthly]

    Completed EARLY_PHASE1

  5. Sep 2021 — Dec 2022 [monthly]

    Completed EARLY_PHASE1

▶ Show 9 earlier versions

  1. Jan 2021 — Sep 2021 [monthly]

    Completed EARLY_PHASE1

  2. Sep 2020 — Jan 2021 [monthly]

    Completed EARLY_PHASE1

  3. Aug 2019 — Sep 2020 [monthly]

    Completed EARLY_PHASE1

    Status: Active Not Recruiting → Completed

  4. Jun 2019 — Aug 2019 [monthly]

    Active Not Recruiting EARLY_PHASE1

  5. Apr 2019 — Jun 2019 [monthly]

    Active Not Recruiting EARLY_PHASE1

    Status: Recruiting → Active Not Recruiting

  6. Jun 2018 — Apr 2019 [monthly]

    Recruiting EARLY_PHASE1

  7. May 2018 — Jun 2018 [monthly]

    Recruiting EARLY_PHASE1

  8. Mar 2018 — May 2018 [monthly]

    Recruiting EARLY_PHASE1

    Status: Not Yet Recruiting → Recruiting

  9. Sep 2017 — Mar 2018 [monthly]

    Not Yet Recruiting EARLY_PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Duke University
  • National Institute on Drug Abuse (NIDA)
  • The Emmes Company, LLC
Data source: Duke University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations